Steven D.E. Sullivan

Steven D.E. Sullivan is a Senior Advisor in Medicinal Chemistry at Eli Lilly and Company, where they have been since 2024. Previously, they worked at DICE Therapeutics and held multiple roles at Theravance Biopharma, where they contributed to several projects, including the development of clinical candidates TD-8236 and TD-1058. Steven conducted undergraduate and graduate research at the University of California, San Diego, earning a Bachelor of Science in Chemistry and a Master of Science in Synthetic Organic Chemistry. Their expertise includes the design and synthesis of novel compounds and optimizing reaction conditions in medicinal chemistry.